{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,27]],"date-time":"2025-08-27T16:00:29Z","timestamp":1756310429406},"reference-count":98,"publisher":"S.C. JURNALUL PENTRU MEDICINA SI VIATA S.R.L","issue":"2","license":[{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JMedLife"],"abstract":"<jats:p>The last decades showed a worrying increase in the evolution of cardiovascular diseases towards different stages of heart failure (HF), as a stigma of the western lifestyle. MicroRNAs (miRNAs), non-coding RNAs, which are approximately 22-nucleotide long, were shown to regulate gene expression at the post-transcriptional level and play a role in the pathogenesis and progression of HF. miRNAs research is of high interest nowadays, as these molecules display mechanisms of action that can influence the course of evolution of common chronic diseases, including HF. The potential of post-transcriptional regulation by miRNAs concerning the diagnosis, management, and therapy for HF represents a new promising approach in the accurate assessment of cardiovascular diseases. This review aims to assess the current knowledge of miRNAs in cardiovascular diseases, especially right-sided heart failure and hepatomegaly. Moreover, attention is focused on their role as potential molecular biomarkers and more promising aspects involving miRNAs as future therapeutic targets in the pathophysiology of HF.<\/jats:p>","DOI":"10.25122\/jml-2021-0071","type":"journal-article","created":{"date-parts":[[2021,10,13]],"date-time":"2021-10-13T08:20:42Z","timestamp":1634113242000},"page":"142-147","source":"Crossref","is-referenced-by-count":7,"title":["MicroRNAs as monitoring markers for right-sided heart failure and congestive hepatopathy"],"prefix":"10.25122","volume":"14","author":[{"given":"Ruxandra Florentina","family":"Ionescu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"Department of Cardiology I, Central Military Emergency University Hospital Dr. Carol Davila, Bucharest, Romania","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sanda Maria","family":"Cretoiu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"Department of Morphological Sciences, Cell and Molecular Biology and Histology, Carol Davila University of Medicine and Pharmacy, Bucharest, Romania","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"*Corresponding Author: Sanda Maria Cretoiu, Department of Morphological Sciences, Cell and Molecular Biology and Histology, Carol Davila University of Medicine and Pharmacy, Bucharest, Romania. E-mail: sanda@cretoiu.ro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"10755","published-online":{"date-parts":[[2021,3]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","unstructured":"Wang H, Cai J. The role of microRNAs in heart failure. Biochimica et Biophysica Acta Mol. Basis Dis.,2017; doi: 10.1016\/j.bbadis.2016.11.034","DOI":"10.1016\/j.bbadis.2016.11.034"},{"key":"ref2","doi-asserted-by":"crossref","unstructured":"Johnson FL. Pathophysiology and Etiology of Heart Failure. Cardiology Clinics, 2014. doi: 10.1016\/j.ccl.2013.09.015","DOI":"10.1016\/j.ccl.2013.09.015"},{"key":"ref3","unstructured":"Types of heart failure. InformedHealth 2018. Cologne, Germany: Institute for Quality and Efficiency in Health Care (IQWiG); https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK481485\/?report=classi. dHealth.org"},{"key":"ref4","doi-asserted-by":"crossref","unstructured":"Xia T, Li J, Cheng H, Zhang C, Zhang Y. Small-Molecule Regulators of MicroRNAs in Biomedicine. Drug Dev. Res., 2015, doi: 10.1002\/ddr.21271.","DOI":"10.1002\/ddr.21271"},{"key":"ref5","doi-asserted-by":"crossref","unstructured":"Sheu-Gruttadauria J, Pawlica P, Klum SM, Wang S, Yario TA, Schirle Oakdale NT, Steitz JA, McRae IJ. Structural Basis for Target-Directed MicroRNA Degradation. Mol. Cell, 2019, 75 (6): 1243\u20131255","DOI":"10.1016\/j.molcel.2019.06.019"},{"key":"ref6","doi-asserted-by":"crossref","unstructured":"O'Brien J, Hayder H, Zayed Y, Peng C. Overview of MicroRNA Biogenesis, Mechanisms of Actions, and Circulation. Front Endocrinol (Lausanne). 2018. doi: 10.3389\/fendo.2018.00402.","DOI":"10.3389\/fendo.2018.00402"},{"key":"ref7","doi-asserted-by":"crossref","unstructured":"Zaporozhchenko IA, Rykova EY, Laktionov PP. The Fundamentals of miRNA Biology: Structure, Biogenesis, and Regulatory Functions. Russ J Bioorg Chem. 2020. https:\/\/doi.org\/10.1134\/S106816202001015X","DOI":"10.1134\/S106816202001015X"},{"key":"ref8","doi-asserted-by":"crossref","unstructured":"Lee RC, Feinbaum RL, Ambros V. The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell. 1993. doi: 10.1016\/0092-8674(93)90529-y.","DOI":"10.1016\/0092-8674(93)90529-Y"},{"key":"ref9","doi-asserted-by":"crossref","unstructured":"Cretoiu D, Xu J, Xiao J, Suciu N, Cretoiu SM. Circulating MicroRNAs as Potential Molecular Biomarkers in Pathophysiological Evolution of Pregnancy. Dis Markers. 2016; doi:10.1155\/2016\/3851054","DOI":"10.1155\/2016\/3851054"},{"key":"ref10","doi-asserted-by":"crossref","unstructured":"Staicu CE, Predescu DV, Rusu CM, Radu BM, Cretoiu D, Suciu N, Cre\u021boiu SM, Voinea SC. Role of microRNAs as Clinical Cancer Biomarkers for Ovarian Cancer: A Short Overview. Cells. 2020; doi:10.3390\/cells9010169","DOI":"10.3390\/cells9010169"},{"key":"ref11","doi-asserted-by":"crossref","unstructured":"Deftu AT, Radu BM, Cretoiu D, Deftu AF, Cretoiu SM, Xiao J. Exosomes as intercellular communication messengers for cardiovascular and cerebrovascular diseases. Exosomes. 2020. https:\/\/doi.org\/10.1016\/B978-0-12-816053-4.00009-2","DOI":"10.1016\/B978-0-12-816053-4.00009-2"},{"key":"ref12","doi-asserted-by":"crossref","unstructured":"Wang J, Chen J, Subrata S. MicroRNA as biomarkers and diagnostics. J. Cell. Physiol.2015. https:\/\/doi.org\/10.1002\/jcp.25056","DOI":"10.1002\/jcp.25056"},{"key":"ref13","doi-asserted-by":"crossref","unstructured":"Khoury S, Tran N. Circulating microRNAs: Potential biomarkers for common malignancies. Biomarkers in Medicine. 2015. doi: 10.2217\/bmm.14.102","DOI":"10.2217\/bmm.14.102"},{"key":"ref14","doi-asserted-by":"crossref","unstructured":"Duic\u0103 F, Condrat CE, D\u0103nila CA, Boboc AE, Radu MR, Xiao J, Li X, Cre\u0163oiu SM, Suciu N, Cre\u0163oiu D, Predescu DV. MiRNAs: A Powerful Tool in Deciphering Gynecological Malignancies. Front Oncol. 2020. doi: 10.3389\/fonc.2020.591181.","DOI":"10.3389\/fonc.2020.591181"},{"key":"ref15","doi-asserted-by":"crossref","unstructured":"Bei Y, Tao L, Cretoiu D, Cretoiu SM, Xiao J. MicroRNAs Mediate Beneficial Effects of Exercise in Heart. Adv Exp Med Biol. 2017. doi: 10.1007\/978-981-10-4304-8_15.","DOI":"10.1007\/978-981-10-4304-8_15"},{"key":"ref16","doi-asserted-by":"crossref","unstructured":"Gallo A, Tandon M, Alevizos I, Illei GG. The majority of microRNAs detectable in serum and saliva is concentrated in exosomes. PLoS One. 2012. doi:10.1371\/journal.pone.0030679","DOI":"10.1371\/journal.pone.0030679"},{"key":"ref17","doi-asserted-by":"crossref","unstructured":"Turchinovich A, Weiz L, Langheinz A, Burwinkel B. Characterization of extracellular circulating microRNA. Nucleic Acids Res. 2011. doi: 10.1093\/nar\/gkr254","DOI":"10.1093\/nar\/gkr254"},{"key":"ref18","doi-asserted-by":"crossref","unstructured":"Canfr\u00e1n-Duque A, Lin CS, Goedeke L, Su\u00e1rez Y, Fern\u00e1ndez-Hernando C. Micro-RNAs and High-Density Lipoprotein Metabolism. Arterioscler Thromb Vasc Biol. 2016. doi: 10.1161\/ATVBAHA.116.307028.","DOI":"10.1161\/ATVBAHA.116.307028"},{"key":"ref19","doi-asserted-by":"crossref","unstructured":"Vickers KC, Palmisano BT, Shoucri BM, Shamburek RD, Remaley AT. MicroRNAs are transported in plasma and delivered to recipient cells by high-density lipoproteins. Nat Cell Biol. 2011. doi: 10.1038\/ncb2210.","DOI":"10.1038\/ncb2210"},{"key":"ref20","doi-asserted-by":"crossref","unstructured":"Tabet F, Vickers KC, Cuesta Torres LF, Wiese CB, Shoucri BM, Lambert G, Catherinet C, Prado-Lourenco L, Levin MG, Thacker S, Sethupathy P, Barter PJ, Remaley AT, Rye KA. HDL-transferred microRNA-223 regulates ICAM-1 expression in endothelial cells. Nat Commun. 2014. doi: 10.1038\/ncomms4292.","DOI":"10.1038\/ncomms4292"},{"key":"ref21","doi-asserted-by":"crossref","unstructured":"Wang K, Zhang S, Weber J, Baxter D, Galas DJ. Export of microRNAs and microRNA-protective protein by mammalian cells. Nucleic Acids Res. 2010; doi: 10.1093\/nar\/gkq601.","DOI":"10.1093\/nar\/gkq601"},{"key":"ref22","doi-asserted-by":"crossref","unstructured":"Arroyo JD, Chevillet JR, Kroh EM, Ruf IK, Pritchard CC, Gibson DF, Mitchell PS, Bennett CF, Pogosova-Agadjanyan EL, Stirewalt DL, Tait JF, Tewari M. Argonaute2 complexes carry a population of circulating microRNAs independent of vesicles in human plasma. Proc. Natl. Acad. Sci. U. S. A.; 2011. 108 (12):5003\u20135008","DOI":"10.1073\/pnas.1019055108"},{"key":"ref23","doi-asserted-by":"crossref","unstructured":"Turchinovich A, Weiz L, Burwinkel B. Extracellular miRNAs: the mystery of their origin and function. Trends Biochem Sci. 2012. doi: 10.1016\/j.tibs.2012.08.003","DOI":"10.1016\/j.tibs.2012.08.003"},{"key":"ref24","doi-asserted-by":"crossref","unstructured":"Condrat CE, Varlas VN, Duica F, Antoniadis P, Danila CA, Cretoiu D, Suciu N, Cretoiu SM, Voinea SC. Pregnancy - Related Extracellular Vesicles Revisited. Int. J. Mol. Sci. 2021. https:\/\/doi.org\/10.3390\/ijms22083904","DOI":"10.3390\/ijms22083904"},{"key":"ref25","doi-asserted-by":"crossref","unstructured":"Bei Y, Yu P, Cretoiu D, Cretoiu SM, Xiao J. Exosomes-Based Biomarkers for the Prognosis of Cardiovascular Diseases. Adv Exp Med Biol. 2017. doi: 10.1007\/978-981-10-4397-0_5.","DOI":"10.1007\/978-981-10-4397-0_5"},{"key":"ref26","doi-asserted-by":"crossref","unstructured":"Cretoiu D, Xu J, Xiao J, Cretoiu SM. Telocytes and Their Extracellular Vesicles-Evidence and Hypotheses. Int J Mol Sci. 2016. doi: 10.3390\/ijms17081322.","DOI":"10.3390\/ijms17081322"},{"key":"ref27","doi-asserted-by":"crossref","unstructured":"Sanei M, Chen X. Mechanisms of microRNA turnover. Curr Opin Plant Biol. 2015. doi:10.1016\/j.pbi.2015.07.008","DOI":"10.1016\/j.pbi.2015.07.008"},{"key":"ref28","doi-asserted-by":"crossref","unstructured":"Chen X, Ba Y, Ma L, Cai X, Yin Y, Wang K, Guo J, Zhang Y, Chen J, Guo X, Li Q, Li X, Wang W, Zhang Y, Wang J, Jiang X, Xiang Y, Xu C, Zheng P, Zhang J, Li R, Zhang H, Shang X, Gong T, Ning G, Wang J, Zen K, Zhang J, Zhang CY. Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases. Cell Res. 2008. doi: 10.1038\/cr.2008.282.","DOI":"10.1038\/cr.2008.282"},{"key":"ref29","doi-asserted-by":"crossref","unstructured":"Cogswell JP, Ward J, Taylor IA, Waters M, Shi Y, Cannon B, Kelnar K, Kemppainen J, Brown D, Chen C, Prinjha RK, Richardson JC, Saunders AM, Roses AD, Richards CA. Identification of miRNA changes in Alzheimer's disease brain and CSF yields putative biomarkers and insights into disease pathways. J Alzheimers Dis. 2008. doi: 10.3233\/jad-2008-14103.","DOI":"10.3233\/JAD-2008-14103"},{"key":"ref30","doi-asserted-by":"crossref","unstructured":"Zhou Q, Li M, Wang X, Li Q, Wang T, Zhu Q, Zhou X, Wang X, Gao X, Li X. Immune-related microRNAs are abundant in breast milk exosomes. Int J Biol Sci. 2012. doi: 10.7150\/ijbs.8.118.","DOI":"10.7150\/ijbs.8.118"},{"key":"ref31","doi-asserted-by":"crossref","unstructured":"Weber JA, Baxter DH, Zhang S, Huang DY, Huang KH, Lee MJ, Galas DJ, Wang K. The microRNA spectrum in 12 body fluids. Clin Chem. 2010. doi: 10.1373\/clinchem.2010.147405.","DOI":"10.1373\/clinchem.2010.147405"},{"key":"ref32","doi-asserted-by":"crossref","unstructured":"da Silveira JC, Veeramachaneni DN, Winger QA, Carnevale EM, Bouma GJ. Cell-secreted vesicles in equine ovarian follicular fluid contain miRNAs and proteins: a possible new form of cell communication within the ovarian follicle. Biol Reprod. 2012. doi: 10.1095\/biolreprod.111.093252.","DOI":"10.1095\/biolreprod.111.093252"},{"key":"ref33","doi-asserted-by":"crossref","unstructured":"Neagu M, Constantin C, Cretoiu SM, Zurac S. miRNAs in the Diagnosis and Prognosis of Skin Cancer. Front Cell Dev Biol. 2020. doi: 10.3389\/fcell.2020.00071.","DOI":"10.3389\/fcell.2020.00071"},{"key":"ref34","doi-asserted-by":"crossref","unstructured":"Bei Y, Chen T, Banciu DD, Cretoiu D, Xiao J. Circulating Exosomes in Cardiovascular Diseases. Adv Exp Med Biol. 2017. doi: 10.1007\/978-981-10-4397-0_17.","DOI":"10.1007\/978-981-10-4397-0_17"},{"key":"ref35","doi-asserted-by":"crossref","unstructured":"Iftikhar H, Carney GE. Evidence and potential in vivo functions for biofluid miRNAs: From expression profiling to functional testing: Potential roles of extracellular miRNAs as indicators of physiological change and as agents of intercellular information exchange. Bioessays. 2016. doi: 10.1002\/bies.201500130.","DOI":"10.1002\/bies.201500130"},{"key":"ref36","doi-asserted-by":"crossref","unstructured":"Cretoiu SM. Circulating microRNAs in cardiovascular diseases : recent progress and challenges. J. Hypertens. Res. 2016. 2(1):15\u201318.","DOI":"10.1155\/2016\/3851054"},{"key":"ref37","doi-asserted-by":"crossref","unstructured":"Foshay KM, Gallicano GI. Small RNAs, big potential: the role of MicroRNAs in stem cell function. Curr Stem Cell Res Ther. 2007. doi: 10.2174\/157488807782793781.","DOI":"10.2174\/157488807782793781"},{"key":"ref38","doi-asserted-by":"crossref","unstructured":"Georgantas RW 3rd, Hildreth R, Morisot S, Alder J, Liu CG, Heimfeld S, Calin GA, Croce CM, Civin CI. CD34+ hematopoietic stem-progenitor cell microRNA expression and function: a circuit diagram of differentiation control. Proc Natl Acad Sci U S A. 2007. doi: 10.1073\/pnas.0610983104.","DOI":"10.1073\/pnas.0610983104"},{"key":"ref39","doi-asserted-by":"crossref","unstructured":"Felli N, Fontana L, Pelosi E, Botta R, Bonci D, Facchiano F, Liuzzi F, Lulli V, Morsilli O, Santoro S, Valtieri M, Calin GA, Liu CG, Sorrentino A, Croce CM, Peschle C. MicroRNAs 221 and 222 inhibit normal erythropoiesis and erythroleukemic cell growth via kit receptor down-modulation. Proc Natl Acad Sci U S A. 2005. doi: 10.1073\/pnas.0506216102.","DOI":"10.1182\/blood.V106.11.830.830"},{"key":"ref40","doi-asserted-by":"crossref","unstructured":"Fazi F, Rosa A, Fatica A, Gelmetti V, De Marchis ML, Nervi C, Bozzoni I. A minicircuitry comprised of microRNA-223 and transcription factors NFI-A and C\/EBPalpha regulates human granulopoiesis. Cell. 2005. doi: 10.1016\/j.cell.2005.09.023.","DOI":"10.1016\/j.cell.2005.09.023"},{"key":"ref41","doi-asserted-by":"crossref","unstructured":"Chen CZ, Li L, Lodish HF, Bartel DP. MicroRNAs modulate hematopoietic lineage differentiation. Science. 2004. doi: 10.1126\/science.1091903.","DOI":"10.1126\/science.1091903"},{"key":"ref42","doi-asserted-by":"crossref","unstructured":"Krichevsky AM, Sonntag KC, Isacson O, Kosik KS. Specific microRNAs modulate embryonic stem cell-derived neurogenesis. Stem Cells. 2006. doi: 10.1634\/stemcells.2005-0441.","DOI":"10.1634\/stemcells.2005-0441"},{"key":"ref43","doi-asserted-by":"crossref","unstructured":"Anderson C, Catoe H, Werner R. MIR-206 regulates connexin43 expression during skeletal muscle development. Nucleic Acids Res. 2006. doi: 10.1093\/nar\/gkl743.","DOI":"10.1093\/nar\/gkl743"},{"key":"ref44","doi-asserted-by":"crossref","unstructured":"Chen JF, Mandel EM, Thomson JM, Wu Q, Callis TE, Hammond SM, Conlon FL, Wang DZ. The role of microRNA-1 and microRNA-133 in skeletal muscle proliferation and differentiation. Nat Genet. 2006. doi: 10.1038\/ng1725.","DOI":"10.1038\/ng1725"},{"key":"ref45","doi-asserted-by":"crossref","unstructured":"Roderburg C, Luedde T. Circulating microRNAs as markers of liver inflammation, fibrosis and cancer. J Hepatol. 2014. doi: 10.1016\/j.jhep.2014.07.017.","DOI":"10.1016\/j.jhep.2014.07.017"},{"key":"ref46","doi-asserted-by":"crossref","unstructured":"Sohn W, Kim J, Kang SH, Yang SR, Cho JY, Cho HC, Shim SG, Paik YH. Serum exosomal microRNAs as novel biomarkers for hepatocellular carcinoma. Exp Mol Med. 2015. doi: 10.1038\/emm.2015.68.","DOI":"10.1038\/emm.2015.68"},{"key":"ref47","unstructured":"Pereira-da-Silva T, Coutinho Cruz M, Carrusca C, Cruz Ferreira R, Napole\u00e3o P, Mota Carmo M. Circulating microRNA profiles in different arterial territories of stable atherosclerotic disease: a systematic review. Am J Cardiovasc Dis. 2018; 8(1):1\u201313."},{"key":"ref48","doi-asserted-by":"crossref","unstructured":"Kehat I, Molkentin JD. Molecular pathways underlying cardiac remodeling during pathophysiological stimulation. Circulation. 2010. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.110.942268","DOI":"10.1161\/CIRCULATIONAHA.110.942268"},{"key":"ref49","doi-asserted-by":"crossref","unstructured":"Navickas R, Gal D, Laucevi\u010dius A, Taparauskaite A, Zdanyte M, Holvoet P. Identifying circulating microRNAs as biomarkers of cardiovascular disease: A systematic review. Cardiovasc. Res.2016. https:\/\/doi.org\/10.1093\/cvr\/cvw174","DOI":"10.1093\/cvr\/cvw174"},{"key":"ref50","doi-asserted-by":"crossref","unstructured":"Huang X, Li Z, Bai B, Li X, Li Z. High expression of microRNA-208 is associated with cardiac hypertrophy via the negative regulation of the sex-determining region Y-box 6 protein. Exp Ther Med. 2015. doi: 10.3892\/etm.2015.2645.","DOI":"10.3892\/etm.2015.2645"},{"key":"ref51","doi-asserted-by":"crossref","unstructured":"Ucar A, Gupta SK, Fiedler J, Erikci E, Kardasinski M, Batkai S, Dangwal S, Kumarswamy R, Bang C, Holzmann A, Remke J, Caprio M, Jentzsch C, Engelhardt S, Geisendorf S, Glas C, Hofmann TG, Nessling M, Richter K, Schiffer M, Carrier L, Napp LC, Bauersachs J, Chowdhury K, Thum T. The miRNA-212\/132 family regulates both cardiac hypertrophy and cardiomyocyte autophagy. Nat. Commun. 2012. https:\/\/doi.org\/10.1038\/ncomms2090","DOI":"10.1038\/ncomms2090"},{"key":"ref52","doi-asserted-by":"crossref","unstructured":"Sygitowicz G, Tomaniak M, B\u0142aszczyk O, Ko\u0142towski \u0141, Filipiak KJ, Sitkiewicz D. Circulating microribonucleic acids miR-1, miR-21 and miR-208a in patients with symptomatic heart failure: Preliminary results. Arch Cardiovasc Dis. 2015. doi: 10.1016\/j.acvd.2015.07.003","DOI":"10.1016\/j.acvd.2015.07.003"},{"key":"ref53","doi-asserted-by":"crossref","unstructured":"da Costa Martins PA, Salic K, Gladka MM, Armand AS, Leptidis S, el Azzouzi H, Hansen A, Coenen-de Roo CJ, Bierhuizen MF, van der Nagel R, van Kuik J, de Weger R, de Bruin A, Condorelli G, Arbones ML, Eschenhagen T, De Windt LJ. MicroRNA-199b targets the nuclear kinase Dyrk1a in an auto-amplification loop promoting calcineurin\/NFAT signalling. Nat Cell Biol. 2010. doi: 10.1038\/ncb2126.","DOI":"10.1038\/ncb2126"},{"key":"ref54","doi-asserted-by":"crossref","unstructured":"Karakikes I, Chaanine AH, Kang S, Mukete BN, Jeong D, Zhang S, Hajjar RJ, Lebeche D. Therapeutic cardiac-targeted delivery of miR-1 reverses pressure overload-induced cardiac hypertrophy and attenuates pathological remodeling. J Am Heart Assoc. 2013. doi: 10.1161\/JAHA.113.000078.","DOI":"10.1161\/JAHA.113.000078"},{"key":"ref55","doi-asserted-by":"crossref","unstructured":"Feng B, Chen S, George B, Feng Q, Chakrabarti S. miR133a regulates cardiomyocyte hypertrophy in diabetes. Diabetes Metab Res Rev. 2010. doi: 10.1002\/dmrr.1054.","DOI":"10.1002\/dmrr.1054"},{"key":"ref56","doi-asserted-by":"crossref","unstructured":"Ganesan J, Ramanujam D, Sassi Y, Ahles A, Jentzsch C, Werfel S, Leierseder S, Loyer X, Giacca M, Zentilin L, Thum T, Laggerbauer B, Engelhardt S. MiR-378 controls cardiac hypertrophy by combined repression of mitogen-activated protein kinase pathway factors,\u201d Circulation. 2013. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.112.000882","DOI":"10.1161\/CIRCULATIONAHA.112.000882"},{"key":"ref57","doi-asserted-by":"crossref","unstructured":"Kim JO, Song DW, Kwon EJ, Hong SE, Song HK, Min CK, Kim DH. miR-185 plays an anti-hypertrophic role in the heart via multiple targets in the calcium-signaling pathways. PLoS One. 2015. doi: 10.1371\/journal.pone.0122509.","DOI":"10.1371\/journal.pone.0122509"},{"key":"ref58","doi-asserted-by":"crossref","unstructured":"Yang Y, Zhou Y, Cao Z, Tong XZ, Xie HQ, Luo T, Hua XP, Wang HQ. miR-155 functions downstream of angiotensin II receptor subtype 1 and calcineurin to regulate cardiac hypertrophy. Exp Ther Med. 2016. doi: 10.3892\/etm.2016.3506.","DOI":"10.3892\/etm.2016.3506"},{"key":"ref59","doi-asserted-by":"crossref","unstructured":"Xin M, Olson EN, Bassel-Duby R. Mending broken hearts: cardiac development as a basis for adult heart regeneration and repair. Nat Rev Mol Cell Biol. 2013. doi: 10.1038\/nrm3619.","DOI":"10.1038\/nrm3619"},{"key":"ref60","doi-asserted-by":"crossref","unstructured":"Hulsmans M, Holvoet P. MicroRNA-containing microvesicles regulating inflammation in association with atherosclerotic disease. Cardiovasc Res. 2013. doi: 10.1093\/cvr\/cvt161.","DOI":"10.1093\/cvr\/cvt161"},{"key":"ref61","doi-asserted-by":"crossref","unstructured":"Jansen F, Yang X, Proebsting S, Hoelscher M, Przybilla D, Baumann K, Schmitz T, Dolf A, Endl E, Franklin BS, Sinning JM, Vasa-Nicotera M, Nickenig G, Werner N. MicroRNA expression in circulating microvesicles predicts cardiovascular events in patients with coronary artery disease. J Am Heart Assoc. 2014. doi: 10.1161\/JAHA.114.001249.","DOI":"10.1161\/JAHA.114.001249"},{"key":"ref62","doi-asserted-by":"crossref","unstructured":"Jansen F, Yang X, Hoelscher M, Cattelan A, Schmitz T, Proebsting S, Wenzel D, Vosen S, Franklin BS, Fleischmann BK, Nickenig G, Werner N. Endothelial microparticle-mediated transfer of microRNA-126 promotes vascular endothelial cell repair via SPRED1 and is abrogated in glucose-damaged endothelial microparticles. Circulation. 2013. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.113.001720","DOI":"10.1161\/CIRCULATIONAHA.113.001720"},{"key":"ref63","doi-asserted-by":"crossref","unstructured":"Villar AV, Garc\u00eda R, Merino D, Llano M, Cobo M, Montalvo C, Mart\u00edn-Dur\u00e1n R, Hurl\u00e9 MA, Nistal JF. Myocardial and circulating levels of microRNA-21 reflect left ventricular fibrosis in aortic stenosis patients. Int J Cardiol. 2013. doi: 10.1016\/j.ijcard.2012.07.021.","DOI":"10.1016\/j.ijcard.2012.07.021"},{"key":"ref64","doi-asserted-by":"crossref","unstructured":"He X, Zhang K, Gao X, Li L, Tan H, Chen J, Zhou Y. Rapid atrial pacing induces myocardial fibrosis by down-regulating Smad7 via microRNA-21 in rabbit. Heart Vessels. 2016. doi: 10.1007\/s00380-016-0808-z.","DOI":"10.1007\/s00380-016-0808-z"},{"key":"ref65","doi-asserted-by":"crossref","unstructured":"Li L, Ren S, Hao X, Zhen Z, Ji L, Ji H. MicroRNA-29b inhibits human vascular smooth muscle cell proliferation via targeting the TGF-\u03b2\/Smad3 signaling pathway. Exp Ther Med. 2021. doi: 10.3892\/etm.2021.9923.","DOI":"10.3892\/etm.2021.9923"},{"key":"ref66","doi-asserted-by":"crossref","unstructured":"Pan Z, Sun X, Shan H, Wang N, Wang J, Ren J, Feng S, Xie L, Lu C, Yuan Y, Zhang Y, Wang Y, Lu Y, Yang B. MicroRNA-101 inhibited postinfarct cardiac fibrosis and improved left ventricular compliance via the FBJ osteosarcoma oncogene\/transforming growth factor-\u03b21 pathway. Circulation. 2012. doi: 10.1161\/CIRCULATIONAHA.112.094524.","DOI":"10.1161\/CIRCULATIONAHA.112.094524"},{"key":"ref67","doi-asserted-by":"crossref","unstructured":"Wang J, Huang W, Xu R, Nie Y, Cao X, Meng J, Xu X, Hu S, Zheng Z. MicroRNA-24 regulates cardiac fibrosis after myocardial infarction. J Cell Mol Med. 2012. doi: 10.1111\/j.1582-4934.2012.01523.x.","DOI":"10.1111\/j.1582-4934.2012.01523.x"},{"key":"ref68","doi-asserted-by":"crossref","unstructured":"Oka T, Akazawa H, Naito AT, Komuro I. Angiogenesis and cardiac hypertrophy: maintenance of cardiac function and causative roles in heart failure. Circ Res. 2014. doi: 10.1161\/CIRCRESAHA.114.300507.","DOI":"10.1161\/CIRCRESAHA.114.300507"},{"key":"ref69","doi-asserted-by":"crossref","unstructured":"Bonauer A, Carmona G, Iwasaki M, Mione M, Koyanagi M, Fischer A, Burchfield J, Fox H, Doebele C, Ohtani K, Chavakis E, Potente M, Tjwa M, Urbich C, Zeiher AM, Dimmeler S. MicroRNA-92a controls angiogenesis and functional recovery of ischemic tissues in mice. Science. 2009. doi: 10.1126\/science.1174381.","DOI":"10.1126\/science.1174381"},{"key":"ref70","doi-asserted-by":"crossref","unstructured":"Fish JE, Santoro MM, Morton SU, Yu S, Yeh RF, Wythe JD, Ivey KN, Bruneau BG, Stainier DY, Srivastava D. miR-126 regulates angiogenic signaling and vascular integrity. Dev Cell. 2008. doi: 10.1016\/j.devcel.2008.07.008.","DOI":"10.1016\/j.devcel.2008.07.008"},{"key":"ref71","doi-asserted-by":"crossref","unstructured":"Hu S, Huang M, Li Z, et al. MicroRNA-210 as a novel therapy for treatment of ischemic heart disease. Circulation. 2010. doi:10.1161\/CIRCULATIONAHA.109.928424","DOI":"10.1161\/CIRCULATIONAHA.109.928424"},{"key":"ref72","doi-asserted-by":"crossref","unstructured":"Doebele C, Bonauer A, Fischer A, Scholz A, Reiss Y, Urbich C, Hofmann WK, Zeiher AM, Dimmeler S. Members of the microRNA-17-92 cluster exhibit a cell-intrinsic antiangiogenic function in endothelial cells. Blood, https:\/\/doi.org\/10.1182\/blood-2010-01-264812","DOI":"10.1182\/blood-2010-01-264812"},{"key":"ref73","doi-asserted-by":"crossref","unstructured":"Ohyagi-Hara C, Sawada K, Kamiura S, Tomita Y, Isobe A, Hashimoto K, Kinose Y, Mabuchi S, Hisamatsu T, Takahashi T, Kumasawa K, Nagata S, Morishige K, Lengyel E, Kurachi H, Kimura T. miR-92a inhibits peritoneal dissemination of ovarian cancer cells by inhibiting integrin \u03b15 expression. Am J Pathol. 2013. doi: 10.1016\/j.ajpath.2013.01.039.","DOI":"10.1016\/j.ajpath.2013.01.039"},{"key":"ref74","doi-asserted-by":"crossref","unstructured":"Galluzzi L, Bravo-San Pedro JM, Vitale I, Aaronson SA, Abrams JM, Adam D, Alnemri ES, Altucci L, Andrews D, Annicchiarico-Petruzzelli M, Baehrecke EH, Bazan NG, Bertrand MJ, Bianchi K, Blagosklonny MV, Blomgren K, Borner C, Bredesen DE, Brenner C, Campanella M, Candi E, Cecconi F, Chan FK, Chandel NS, Cheng EH, Chipuk JE, Cidlowski JA, Ciechanover A, Dawson TM, Dawson VL, De Laurenzi V, De Maria R, Debatin KM, Di Daniele N, Dixit VM, Dynlacht BD, El-Deiry WS, Fimia GM, Flavell RA, Fulda S, Garrido C, Gougeon ML, Green DR, Gronemeyer H, Hajnoczky G, Hardwick JM, Hengartner MO, Ichijo H, Joseph B, Jost PJ, Kaufmann T, Kepp O, Klionsky DJ, Knight RA, Kumar S, Lemasters JJ, Levine B, Linkermann A, Lipton SA, Lockshin RA, L\u00f3pez-Ot\u00edn C, Lugli E, Madeo F, Malorni W, Marine JC, Martin SJ, Martinou JC, Medema JP, Meier P, Melino S, Mizushima N, Moll U, Mu\u00f1oz-Pinedo C, Nu\u00f1ez G, Oberst A, Panaretakis T, Penninger JM, Peter ME, Piacentini M, Pinton P, Prehn JH, Puthalakath H, Rabinovich GA, Ravichandran KS, Rizzuto R, Rodrigues CM, Rubinsztein DC, Rudel T, Shi Y, Simon HU, Stockwell BR, Szabadkai G, Tait SW, Tang HL, Tavernarakis N, Tsujimoto Y, Vanden Berghe T, Vandenabeele P, Villunger A, Wagner EF, Walczak H, White E, Wood WG, Yuan J, Zakeri Z, Zhivotovsky B, Melino G, Kroemer G. Essential versus accessory aspects of cell death: recommendations of the NCCD 2015. Cell Death Differ. 2015. doi: 10.1038\/cdd.2014.137.","DOI":"10.1038\/cdd.2014.137"},{"key":"ref75","doi-asserted-by":"crossref","unstructured":"Xiong H, Luo T, He W, Xi D, Lu H, Li M, Liu J, Guo Z. Up-regulation of miR-138 inhibits hypoxia-induced cardiomyocyte apoptosis via down-regulating lipocalin-2 expression. Exp Biol Med (Maywood). 2016. doi: 10.1177\/1535370215591831.","DOI":"10.1177\/1535370215591831"},{"key":"ref76","doi-asserted-by":"crossref","unstructured":"Wang H, Li J, Chi H, Zhang F, Zhu X, Cai J, Yang X. MicroRNA-181c targets Bcl-2 and regulates mitochondrial morphology in myocardial cells. J Cell Mol Med. 2015. doi: 10.1111\/jcmm.12563.","DOI":"10.1111\/jcmm.12563"},{"key":"ref77","doi-asserted-by":"crossref","unstructured":"Yang Q, Yang K, Li A. microRNA-21 protects against ischemia-reperfusion and hypoxia-reperfusion-induced cardiocyte apoptosis via the phosphatase and tensin homolog\/Akt-dependent mechanism. Mol Med Rep. 2014. doi: 10.3892\/mmr.2014.2068.","DOI":"10.3892\/mmr.2014.2068"},{"key":"ref78","doi-asserted-by":"crossref","unstructured":"Roca-Alonso L, Castellano L, Mills A, Dabrowska AF, Sikkel MB, Pellegrino L, Jacob J, Frampton AE, Krell J, Coombes RC, Harding SE, Lyon AR, Stebbing J. Myocardial MiR-30 downregulation triggered by doxorubicin drives alterations in \u03b2-adrenergic signaling and enhances apoptosis. Cell Death Dis. 2015. doi: 10.1038\/cddis.2015.89.","DOI":"10.1038\/cddis.2015.89"},{"key":"ref79","doi-asserted-by":"crossref","unstructured":"Li H, Fan J, Yin Z, Wang F, Chen C, Wang DW. Identification of cardiac-related circulating microRNA profile in human chronic heart failure. Oncotarget. 2016. doi: 10.18632\/oncotarget.6631.","DOI":"10.18632\/oncotarget.6631"},{"key":"ref80","doi-asserted-by":"crossref","unstructured":"Malik R, Mushtaque RS, Siddiqui UA, Younus A, Aziz MA, Humayun C, Mansoor K, Latif MA, Waheed S, Assad S, Khan I, Bukhari SM, DelCampo D, Adus A, Gannarapu S. Association Between Coronary Artery Disease and MicroRNA: Literature Review and Clinical Perspective. Cureus. 2017. doi: 10.7759\/cureus.1188.","DOI":"10.7759\/cureus.1188"},{"key":"ref81","doi-asserted-by":"crossref","unstructured":"Fortea JI, Puente \u00c1, Cuadrado A, Huelin P, Pell\u00f3n R, Gonz\u00e1lez S\u00e1nchez FJ, Mayorga M, Cagigal ML, Garc\u00eda Carrera I, Cobreros M, Crespo J, F\u00e1brega E. Congestive Hepatopathy. Int J Mol Sci. 2020. doi: 10.3390\/ijms21249420.","DOI":"10.3390\/ijms21249420"},{"key":"ref82","doi-asserted-by":"crossref","unstructured":"Hu J, Xu Y, Hao J, Wang S, Li C, Meng S. MiR-122 in hepatic function and liver diseases. Protein Cell. 2012. doi: 10.1007\/s13238-012-2036-3.","DOI":"10.1007\/s13238-012-2036-3"},{"key":"ref83","doi-asserted-by":"crossref","unstructured":"Tsai WC, Hsu SD, Hsu CS, Lai TC, Chen SJ, Shen R, Huang Y, Chen HC, Lee CH, Tsai TF, Hsu MT, Wu JC, Huang HD, Shiao MS, Hsiao M, Tsou AP. MicroRNA-122 plays a critical role in liver homeostasis and hepatocarcinogenesis. J Clin Invest. 2012. doi: 10.1172\/JCI63455.","DOI":"10.1172\/JCI63455"},{"key":"ref84","doi-asserted-by":"crossref","unstructured":"Hsu SH, Wang B, Kutay H, Bid H, Shreve J, Zhang X, Costinean S, Bratasz A, Houghton P, Ghoshal K. Hepatic loss of miR-122 predisposes mice to hepatobiliary cyst and hepatocellular carcinoma upon diethylnitrosamine exposure. Am J Pathol. 2013. doi: 10.1016\/j.ajpath.2013.08.004.","DOI":"10.1016\/j.ajpath.2013.08.004"},{"key":"ref85","doi-asserted-by":"crossref","unstructured":"Abu-Halima M, Meese E, Saleh MA, Keller A, Abdul-Khaliq H, Raedle-Hurst T. MicroRNA-29b\/c-3p Indicate Advanced Liver Fibrosis\/Cirrhosis in Univentricular Heart Patients With and Without Fontan Palliation. Front Cardiovasc Med. 2021. doi: 10.3389\/fcvm.2020.619083.","DOI":"10.21203\/rs.2.22992\/v1"},{"key":"ref86","doi-asserted-by":"crossref","unstructured":"Ellis KL, Cameron VA, Troughton RW, Frampton CM, Ellmers LJ, Richards AM. Circulating microRNAs as candidate markers to distinguish heart failure in breathless patients. Eur J Heart Fail. 2013. doi: 10.1093\/eurjhf\/hft078.","DOI":"10.1093\/eurjhf\/hft078"},{"key":"ref87","doi-asserted-by":"crossref","unstructured":"Corsten MF, Dennert R, Jochems S, Kuznetsova T, Devaux Y, Hofstra L, Wagner DR, Staessen JA, Heymans S, Schroen B. Circulating MicroRNA-208b and MicroRNA-499 reflect myocardial damage in cardiovascular disease. Circ Cardiovasc Genet. 2010. doi: 10.1161\/CIRCGENETICS.110.957415.","DOI":"10.1161\/CIRCGENETICS.110.958959"},{"key":"ref88","doi-asserted-by":"crossref","unstructured":"Vegter EL, van der Meer P, de Windt LJ, Pinto YM, Voors AA. MicroRNAs in heart failure: from biomarker to target for therapy. Eur J Heart Fail. 2016. doi: 10.1002\/ejhf.495.","DOI":"10.1002\/ejhf.495"},{"key":"ref89","doi-asserted-by":"crossref","unstructured":"Tijsen AJ, Creemers EE, Moerland PD, de Windt LJ, van der Wal AC, Kok WE, Pinto YM. MiR423-5p as a circulating biomarker for heart failure. Circ Res. 2010. doi: 10.1161\/CIRCRESAHA.110.218297.","DOI":"10.1161\/CIRCRESAHA.110.218297"},{"key":"ref90","doi-asserted-by":"crossref","unstructured":"Watson CJ, Gupta SK, O'Connell E, Thum S, Glezeva N, Fendrich J, Gallagher J, Ledwidge M, Grote-Levi L, McDonald K, Thum T. MicroRNA signatures differentiate preserved from reduced ejection fraction heart failure. Eur J Heart Fail. 2015. doi: 10.1002\/ejhf.244.","DOI":"10.1002\/ejhf.244"},{"key":"ref91","doi-asserted-by":"crossref","unstructured":"Wong LL, Armugam A, Sepramaniam S, Karolina DS, Lim KY, Lim JY, Chong JP, Ng JY, Chen YT, Chan MM, Chen Z, Yeo PS, Ng TP, Ling LH, Sim D, Leong KT, Ong HY, Jaufeerally F, Wong R, Chai P, Low AF, Lam CS, Jeyaseelan K, Richards AM. Circulating microRNAs in heart failure with reduced and preserved left ventricular ejection fraction. Eur J Heart Fail. 2015. doi: 10.1002\/ejhf.223.","DOI":"10.1002\/ejhf.223"},{"key":"ref92","doi-asserted-by":"crossref","unstructured":"Qiang L, Hong L, Ningfu W, Huaihong C, Jing W. Expression of miR-126 and miR-508-5p in endothelial progenitor cells is associated with the prognosis of chronic heart failure patients. Int J Cardiol. 2013. doi: 10.1016\/j.ijcard.2013.01.160.","DOI":"10.1016\/j.ijcard.2013.01.160"},{"key":"ref93","doi-asserted-by":"crossref","unstructured":"Ovchinnikova ES, Schmitter D, Vegter EL, Ter Maaten JM, Valente MA, Liu LC, van der Harst P, Pinto YM, de Boer RA, Meyer S, Teerlink JR, O'Connor CM, Metra M, Davison BA, Bloomfield DM, Cotter G, Cleland JG, Mebazaa A, Laribi S, Givertz MM, Ponikowski P, van der Meer P, van Veldhuisen DJ, Voors AA, Berezikov E. Signature of circulating microRNAs in patients with acute heart failure. Eur J Heart Fail. 2016. doi: 10.1002\/ejhf.332.","DOI":"10.1002\/ejhf.332"},{"key":"ref94","doi-asserted-by":"crossref","unstructured":"Zhou Y, Deng L, Zhao D, Chen L, Yao Z, Guo X, Liu X, Lv L, Leng B, Xu W, Qiao G, Shan H. MicroRNA-503 promotes angiotensin II-induced cardiac fibrosis by targeting Apelin-13. J Cell Mol Med. 2016. doi: 10.1111\/jcmm.12754.","DOI":"10.1111\/jcmm.12754"},{"key":"ref95","doi-asserted-by":"crossref","unstructured":"Sygitowicz G, Maciejak-Jastrz\u0119bska A, Sitkiewicz D. MicroRNAs in the development of left ventricular remodeling and postmyocardial infarction heart failure. Pol Arch Intern Med. 2020. doi: 10.20452\/pamw.15137.","DOI":"10.20452\/pamw.15137"},{"key":"ref96","doi-asserted-by":"crossref","unstructured":"Marfella R, Di Filippo C, Potenza N, Sardu C, Rizzo MR, Siniscalchi M, Musacchio E, Barbieri M, Mauro C, Mosca N, Solimene F, Mottola MT, Russo A, Rossi F, Paolisso G, D'Amico M. Circulating microRNA changes in heart failure patients treated with cardiac resynchronization therapy: responders vs. non-responders. Eur J Heart Fail. 2013. doi: 10.1093\/eurjhf\/hft088.","DOI":"10.1093\/eurjhf\/hft088"},{"key":"ref97","doi-asserted-by":"crossref","unstructured":"Elzenaar I, Pinto YM, Van Oort RJ. MicroRNAs in heart failure: New targets in disease management. Clinical Pharmacology and Therapeutics. 2013. https:\/\/doi.org\/10.1038\/clpt.2013.138","DOI":"10.1038\/clpt.2013.138"},{"key":"ref98","doi-asserted-by":"crossref","unstructured":"Kalampogias A, Siasos G, Oikonomou E, Mourouzis K, Bletsa E, Stampouloglou PK, Katsianos E, Vlasis K, Marinos G, Charalambous G, Vavouranakis M, Tousoulis D. MicroRNAs in the Management of Heart Failure. Curr Med Chem. 2021. doi: 10.2174\/0929867328666210218181441.","DOI":"10.2174\/0929867328666210218181441"}],"container-title":["Journal of Medicine and Life"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/medandlife.org\/wp-content\/uploads\/4.-jml-2021-0071.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,12]],"date-time":"2023-01-12T00:11:13Z","timestamp":1673482273000},"score":1,"resource":{"primary":{"URL":"https:\/\/medandlife.org\/wp-content\/uploads\/4.-jml-2021-0071.pdf"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3]]},"references-count":98,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,3]]}},"alternative-id":["JMedLife-14-142"],"URL":"https:\/\/doi.org\/10.25122\/jml-2021-0071","relation":{},"ISSN":["1844-122X","1844-3117"],"issn-type":[{"type":"print","value":"1844-122X"},{"type":"electronic","value":"1844-3117"}],"subject":[],"published":{"date-parts":[[2021,3]]}}}